Portola Pharma (PTLA) Tops Q3 EPS by 6c

Portola Pharma (NASDAQ: PTLA) reported Q3 EPS of ($0.86), $0.06 better than the analyst estimate of ($0.92).

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c